Coya Therapeutics
COYA
4 hedge funds and large institutions have $5.16M invested in Coya Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
11.27% more ownership
Funds ownership: 0% → 11.27% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$2.61M |
| 2 |
GC
Greenlight Capital
New York
|
+$1.83M |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$641K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.66K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $2.65M | +$2.61M | +560,000 | New |
|
|
GC
2
Greenlight Capital
New York
| $1.86M | +$1.83M | +392,444 | New |
|
|
WVP
3
Worth Venture Partners
Fort Lee,
New Jersey
| $638K | +$641K | +137,758 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $5.76K | +$5.66K | +1,215 | New |
|
COYA Hedge Fund Activity: Q4 2022 in Review
4 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q4 2022, worth a combined $5.16M.
Buyers outnumbered sellers: 4 funds opened new COYA positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $2.61M.
- 4 institutional investors held Coya Therapeutics (COYA) as of Q4 2022, up from 0 in Q3 2022.
- Funds reported $5.16M of Coya Therapeutics stock for Q4 2022.
- 4 funds opened new Coya Therapeutics positions in Q4 2022 and 0 closed out, a net change of +4 holders.
- The largest Coya Therapeutics buyer in Q4 2022 was AIGH Capital Management, an estimated $2.61M added.
Based on aggregated 13F filings for Q4 2022.